766 related articles for article (PubMed ID: 25935309)
21. Restoration of Circulating MFGE8 (Milk Fat Globule-EGF Factor 8) Attenuates Cardiac Hypertrophy Through Inhibition of Akt Pathway.
Deng KQ; Li J; She ZG; Gong J; Cheng WL; Gong FH; Zhu XY; Zhang Y; Wang Z; Li H
Hypertension; 2017 Oct; 70(4):770-779. PubMed ID: 28827473
[TBL] [Abstract][Full Text] [Related]
22. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
23. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
24. The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1.
Dadson K; Hauck L; Hao Z; Grothe D; Rao V; Mak TW; Billia F
Sci Rep; 2017 Feb; 7():41490. PubMed ID: 28148912
[TBL] [Abstract][Full Text] [Related]
25. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
26. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
[TBL] [Abstract][Full Text] [Related]
27. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
28. Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.
Liao HH; Zhang N; Meng YY; Feng H; Yang JJ; Li WJ; Chen S; Wu HM; Deng W; Tang QZ
Oxid Med Cell Longev; 2019; 2019():6304058. PubMed ID: 31885808
[TBL] [Abstract][Full Text] [Related]
29. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
[TBL] [Abstract][Full Text] [Related]
30. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
31. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
[TBL] [Abstract][Full Text] [Related]
32. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
33. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
35. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
[TBL] [Abstract][Full Text] [Related]
36. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
37. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
39. Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.
Tian C; Gao L; Zimmerman MC; Zucker IH
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H928-H939. PubMed ID: 29373037
[TBL] [Abstract][Full Text] [Related]
40. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling.
Rubio N; Verrax J; Dewaele M; Verfaillie T; Johansen T; Piette J; Agostinis P
Free Radic Biol Med; 2014 Feb; 67():292-303. PubMed ID: 24269898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
